The Prescription Pathways joint venture will dissolve at the end of 2008, with CVS Caremark and Universal/MemberHealth divvying up the assets of one of the larger Part D plans. As divorces go, this seems amicable. But what about the children? Or in this case, the elderly and disabled Medicare beneficiaries who may be surprised to learn that they have been transferred to a new plan sponsor.
The Prescription Pathways joint venture will dissolve at the end of 2008, with CVS Caremark and Universal/MemberHealth divvying up the assets of one of the larger Part D plans. As divorces go, this seems amicable. But what about the children?
Prescription Pathways was one of the more innovative business arrangements created to launch Part D, a joint venture of CVS...
50% tariffs on US imports from India, a range on others, an uncertain outcome of Section 232 investigations of pharma and talk of BRICS tariffs are making the forecasting environment for the pharma industry extremely difficult, the Pink Sheet finds in this infographic analysis.
The UK drug regulator and England’s health technology assessment agency have joined forces under an information sharing agreement, aimed at accelerating patient access to newly approved medicines by three to six months.
A newly launched UK government inquiry is seeking to learn how viable it would be to bring back domestic control over the entire drug manufacturing pipeline.
Pfizer is in active discussions with Trump on MFN pricing and collaborating with peers on direct sales as an approach to lower drug prices, CEO Albert Bourla said.
